$TECX

$20.34 +$0.39 (1.95%) Close

$TECX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$TECX Management Team

Dr. Peter Mcnamara

Chief Scientific Officer

Age 54

Compensation -

Sex Male

Dr. Marcella Ruddy

Chief Medical Officer

Age 62

Compensation $1.841M USD

Sex Female

Dr. Marc Schwabish

Chief Business Officer

Age 45

Compensation -

Sex Male

Mr. Daniel Ferry

IR Contact Officer

Age -

Compensation -

Sex Male

Dr. Alise Reicin

President

Chief Executive Officer

Director

Age 64

Compensation $5.901M USD

Sex Female

Mr. Daniel Lochner

Chief Financial Officer

Age 42

Compensation $2.284M USD

Sex Male

Mr. Terrance McGuire

Independent Non-Executive Chairman of the Board

Age 69

Compensation $203.1K USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Peter Mcnamara Chief Scientific Officer	54	-	Male
Dr. Marcella Ruddy Chief Medical Officer	62	$1.841M USD	Female
Dr. Marc Schwabish Chief Business Officer	45	-	Male
Mr. Daniel Ferry IR Contact Officer	-	-	Male
Dr. Alise Reicin President Chief Executive Officer Director	64	$5.901M USD	Female
Mr. Daniel Lochner Chief Financial Officer	42	$2.284M USD	Male
Mr. Terrance McGuire Independent Non-Executive Chairman of the Board	69	$203.1K USD	Male

Board of Directors

From the proxy statement filed Apr 24, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

3.0 years

from year joined

CEO also chairs the board

François Nader

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Timothy A. Springer	78	Not stated	Independent	None stated	None stated	Not stated
Stefan Vitorovic	41	Not stated	Independent	None stated	None stated	$251,882
Phillip B. Donenberg	65	Not stated	Independent	None stated	Taysha Gene Therapies, Sensei Biotherapeutics	$253,764
François Nader Board chair	69	2026 0 years	Independent	None stated	Moderna	Not stated
Alise Reicin CEO	65	2020 6 years	Not independent	None stated	Sana Biotechnology, Immatics	Paid as CEO
Praveen Tipirneni	56	Not stated	Independent	None stated	TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics	Not stated
Terrance McGuire Leaving at the meeting	Not stated	Not stated	Independent	None stated	None stated	$280,882

Nominated to join at the meeting

Not on the board yet; they join only if elected.

Jessica Chutter · 65

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$TECX Management Team

Dr. Peter Mcnamara

Dr. Marcella Ruddy

Dr. Marc Schwabish

Mr. Daniel Ferry

Dr. Alise Reicin

Mr. Daniel Lochner

Mr. Terrance McGuire

Board of Directors

Related-party transactions

No related-party transactions disclosed